YourSpace
Build interactive personal pages to aggregate content and own your audience.
Product memo
Content creators, freelancers, and professionals use YourSpace to build interactive personal pages that go beyond basic link-in-bio tools. It aggregates content and embeds media, giving users a central hub for their online presence. The platform offers design flexibility and real-time content management, helping individuals establish a stronger, more customizable online presence.
- For who
- Content creators, freelancers, and professionals
- Solves what
- Build a stunning, interactive personal page to aggregate content and own audience.
- Drag and drop editor
- Customizable themes and blocks
- Real-time analytics
Operator & company
Operators
1 person
Reddit-sourced claim; not official-site verified.
Company
- Team
Indie / lean
- Founded
Jan 2026
- HQ
Pakistan
Operating model
- Business model
Saas
- Platform
Web app
- Audience
Creators
- Payments
Lemon Squeezy
Builder strategy
- Strategy Type
- Niche Specialist
- Stage
- Bootstrapped Lean
- Effort
- Solo Buildable
Source evidence
Evidence sources
About YourSpace Expand
YourSpace provides a no-code product for individuals to create personalized, interactive web pages. It targets content creators, freelancers, and professionals who need more than a basic link-in-bio tool, offering a drag-and-drop builder with customizable themes and blocks.
Users can aggregate links, embed content from platforms like YouTube and GitHub, and access real-time analytics. This allows users to own their audience and centralize their digital footprint, moving beyond the limitations of simpler content aggregators.
In their own words
Your entire
Stop blending in. Build a stunning, interactive page that aggregates your content and owns your audience.
Competitive context
5 peers · Same primary niche · Radar benchmark · YourSpace #5376.
Commercial cues
- Model
- subscription
- Free tier
- Yes
- Trial
- 7 days
Pricing strategy
- • A free tier removes adoption friction for single-page users.
- • 7-day trial lowers adoption risk.
